Efficacy of autologous plasma therapy on clinical symptoms of Chronic Spontaneous Urticaria
Not Applicable
- Conditions
- Chronic Spontaneous Urticaria.Other urticaria (Urticaria: chronic, recurrent periodic)
- Registration Number
- IRCT2016040627260N1
- Lead Sponsor
- Vice-chancellor for Research of Bushehr University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Inclusion criteria are urticaria for more than 2 months; Age over than 15 year old; Consent to participate in the study; Negative Prick skin test for common inhalation and food allergens and normal findings in Lab data such as CBC (Complete Blood Count), ANA (Antinuclear antibody), ESR (Erythrocyte Sedimentation Rate), LFT (Liver Function Test), U/A (Urine Analysis) and S/E (Stool Exam).
Exclusion criteria are Pregnancy; Physical urticaria; Use of corticosteroid and immunosuppressive agents during the last 6 weeks; Use of drugs other than antihistamine and other systemic diseases.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Qualitative clinical symptoms of urticaria. Timepoint: Before the treatment, every week during the treatment and one week after the treatment. Method of measurement: Changes in DLQI (Dermatology Life Quality Index).
- Secondary Outcome Measures
Name Time Method Quantitative clinical symptoms of urticaria. Timepoint: Before the treatment, every week during the treatment for 10 weeks and one week after the treatment. Method of measurement: Changes in TSS (Total Symptoms Score) index.